ARNI versus ACEI/ARB in Reducing Cardiovascular Outcomes after Myocardial Infarction.

Jianqing She,Bowen Lou,Hui Liu,Bo Zhou,Gulinigaer Tuerhong Jiang,Yongbai Luo,Haoyu Wu,Chen Wang,Zuyi Yuan

ESC heart failure（2021）

引用 14|浏览7

暂无评分

摘要

In patients with AMI, ARNI was superior to ACEI/ARB in reducing the long-term adverse cardiovascular outcomes. Subgroup analysis further indicates that ARNI is more likely to benefit patients with LVEF less than 40% and aged less than 60 years.

查看译文

关键词

Acute myocardial infarction,Angiotensin converting enzyme inhibitor (ACEI),Angiotensin receptor blockers (ARB),Sacubitril/valsartan (LCZ696)

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要